HbA1c Test: What Your Results Mean for Diabetes Risk

HbA1c (glycated hemoglobin or A1c) measures the percentage of hemoglobin molecules in your red blood cells that have glucose attached to them. Because red blood cells live approximately 120 days, the test reflects your average blood sugar over the previous 2-3 months:

• Normal: Below 5.7% (estimated average glucose below 117 mg/dL)
• Prediabetes: 5.7-6.4% (estimated average glucose 117-137 mg/dL)
• Diabetes: 6.5% or above (estimated average glucose 140+ mg/dL)

The clinical significance of HbA1c reduction is well-established by landmark trials:

• The UKPDS trial found each 1% reduction in HbA1c was associated with a 37% decrease in microvascular complications (eye, kidney, nerve damage) and a 21% decrease in diabetes-related deaths.
• For people with prediabetes, reducing HbA1c by 0.3-0.5% through lifestyle changes can delay or prevent progression to diabetes by 58% (Diabetes Prevention Program study).

Upload your lab results to WAYJET's Medical Report Analyzer for a comprehensive interpretation of your HbA1c alongside other metabolic markers.

Several conditions can cause falsely high or low HbA1c readings, which is important to understand when interpreting results:

Falsely elevated HbA1c:

• Iron deficiency anemia (the most common cause of false elevation)
• Vitamin B12 or folate deficiency
• Chronic kidney disease (uremia causes carbamylated hemoglobin)
• Chronic alcoholism
• Hypertriglyceridemia

Falsely low HbA1c:

• Hemolytic anemias (sickle cell, thalassemia) — shorter red blood cell lifespan
• Recent blood transfusion
• Chronic liver disease
• Pregnancy (hemodilution)
• EPO therapy or high-dose vitamin C/E supplementation

For people with conditions affecting HbA1c accuracy, alternative measures include:

• Fructosamine: Reflects average glucose over 2-3 weeks (vs. 2-3 months for HbA1c)
• Continuous glucose monitoring (CGM): Provides real-time glucose data including time-in-range, variability, and patterns not captured by HbA1c
• Glycated albumin: Reflects 2-3 week average, useful when hemoglobin turnover is altered

Evidence-based strategies for reducing HbA1c depend on your starting point:

For prediabetes (HbA1c 5.7-6.4%):

• Lifestyle intervention: The Diabetes Prevention Program found 150 minutes/week of moderate exercise plus 7% body weight loss reduced diabetes risk by 58%. This is more effective than metformin alone (31% reduction).
• Dietary changes: Mediterranean and DASH diets both reduce HbA1c by 0.3-0.5%. Reducing refined carbohydrates and increasing fiber (30g+ daily) has the most impact.
• Post-meal walking: Even 10-15 minutes of walking after meals reduces glucose spikes by 17-24%.

For diabetes (HbA1c 6.5%+):

• All of the above lifestyle modifications
• Medication management: Metformin typically reduces HbA1c by 1-1.5%. SGLT2 inhibitors and GLP-1 agonists provide additional reduction with cardiovascular and weight benefits.
• Blood sugar monitoring: Whether through fingerstick testing or CGM, monitoring helps identify patterns and triggers for high glucose.

HbA1c targets:

• Most adults with diabetes: below 7.0% (ADA recommendation)
• Newly diagnosed, young, healthy: below 6.5% (if achievable without significant hypoglycemia)
• Older adults with multiple comorbidities: below 8.0% (less aggressive target to avoid hypoglycemia risk)